How were (COV)'s earnings last quarter?

(COV) (NYSE:COV) released its quarterly earnings data on Wednesday, November, 5th. The healthcare company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.13. The healthcare company had revenue of $2.73 billion for the quarter, compared to analyst estimates of $2.69 billion. (COV)'s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 EPS.

What other stocks do shareholders of (COV) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (COV) investors own include Pfizer (PFE) , Chevron (CVX) , Intel (INTC) , Johnson & Johnson (JNJ) , Boeing (BA) , CVS Health (CVS) , EMC (EMC) , Gilead Sciences (GILD) and JPMorgan Chase & Co. (JPM) .

NYSE:COV

(COV) (COV) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free COV Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 3.88 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (COV) alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About (COV) Stock (NYSE:COV)

Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company’s segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company’s products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

COV Stock News Headlines

April 19, 2024 | usnews.com

Dozens of COVID Virus Mutations Arose in Man With Longest Known Case

April 19, 2024 | theglobeandmail.com

Closing Bell: CI Hlth Care Giants Cov Call ETF flat on Wednesday (FHI-B)

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 18, 2024 | bloomberg.com

Covid Patient’s Infection Lasts Record 613 Days and Spawns New Mutations

April 18, 2024 | msn.com

Lungs Of Young Adults More Susceptible To Covid-19 Causing SARS-CoV-2 Virus, Claims Study

April 17, 2024 | msn.com

New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses

April 17, 2024 | msn.com

Arboviruses, mosquitoes and potential hosts tracked in real time in São Paulo city

April 17, 2024 | msn.com

7 out of 10 Americans think COVID-19 came from a lab

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 17, 2024 | msn.com

Study highlights how age affects nasal cell response to SARS-CoV-2

April 16, 2024 | msn.com

Nasal Cells in Children Shield Against Severe COVID-19

April 16, 2024 | msn.com

Rapid immune response of cells inside nose leads to milder cases of COVID-19 in kids

April 15, 2024 | finance.yahoo.com

Research on Plant-Based SARS-CoV-2 Vaccine to Be Presented at One Health Symposium by PlantPharm BioMed

April 15, 2024 | msn.com

Unlocking the Potential of CRISPR/Cas13 for Antiviral Therapy

April 15, 2024 | msn.com

Cas13d-NCS: A game-changer in RNA virus defense

April 15, 2024 | msn.com

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

April 14, 2024 | msn.com

Study reveals metabolic markers linked to long COVID-19 severity

April 13, 2024 | msn.com

SARS-CoV-2 Positivity Not Linked to New Asthma Diagnosis in Children

April 12, 2024 | msn.com

Study suggests staying current with COVID-19 vaccinations helps combat emerging variants

April 12, 2024 | msn.com

New CRISPR tool orchestrates antiviral defense within cells

April 11, 2024 | msn.com

James Hilston: A total eclipse changes your life

April 11, 2024 | msn.com

Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook

April 10, 2024 | msn.com

Scientists flag previously overlooked type of immune cell as suspected source of severe COVID-19

April 10, 2024 | msn.com

Modeling viral evolution: A novel computational model with application to SARS-CoV-2 dynamics

April 10, 2024 | forbes.com

Toward A Universal Covid Vaccine

April 10, 2024 | msn.com

Study finds survivors of severe COVID face persistent health problems lasting more than a year

April 9, 2024 | msn.com

Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial

See More Headlines

Receive COV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (COV) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/05/2014
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: N/A
Industry: N/A
Sub-Industry: Health Care Equipment
Current Symbol: NYSE:COV
CUSIP: G2554F11
CIK: 1385187
Web: N/A
Phone: +353-1-4381700
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Gary L. Ellis (Age 61)
President, Chief Executive Officer
Charles J. Dockendorff (Age 63)
Chief Financial Officer, Executive Vice President
Bryan C. Hanson (Age 50)
Group President, Covidien
John H. Masterson (Age 54)
Senior Vice President, General Counsel
Michael P. Dunford (Age 54)
Senior Vice President - Human Resources
James C. Clemmer (Age 53)
Senior Vice President and President - Medical Supplies Business
Amy A. McBride-Wendell (Age 53)
Senior Vice President - Strategy and Business Development
Jacqueline F. Strayer (Age 58)
Senior Vice President-Corporate Communications
Michael E. Tarnoff (Age 46)
Senior Vice President,Chief Medical Officer
Peter L. Wehrly (Age 57)
Senior Vice President, Group President - Developed Markets

COV Stock Analysis - Frequently Asked Questions

How were (COV)'s earnings last quarter?: (COV) (NYSE:COV) released its quarterly earnings data on Wednesday, November, 5th. The healthcare company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.13. The healthcare company had revenue of $2.73 billion for the quarter, compared to analyst estimates of $2.69 billion. (COV)'s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 EPS.
What other stocks do shareholders of (COV) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (COV) investors own include Pfizer (PFE), Chevron (CVX), Intel (INTC), Johnson & Johnson (JNJ), Boeing (BA), CVS Health (CVS), EMC (EMC), Gilead Sciences (GILD) and JPMorgan Chase & Co. (JPM).

This page (NYSE:COV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(COV) (COV) Stock Price, News & Analysis

About (COV) Stock (NYSE:COV)

COV Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

COV Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info